Novavax Inc. Stock Sheds 9.3%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Novavax Inc. slipped 9.3% to $9.99 on what proved to be an all-around grim trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 52,867.98 and the NASDAQ Composite Index falling 2.6% to 26,008.86.

This was the stock's second consecutive day of losses.

Novavax Inc. closed 25.4% below its 52-week high of $13.39, which the company achieved on October 5th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 3.8% to $267.61, Pfizer Inc. rose 1.9% to $30.42, and Merck & Co. Inc. fell 1.76% to $147.24.

Trading volume totaled 12.2 million, compared to the 50-day average of 6.8 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 22, 2026 16:34 ET (20:34 GMT)